✦ LIBER ✦

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

✍ Scribed by Hurvitz, S.A.; Peddi, P.F.

Book ID: 121936202
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 24
Category: Article
ISSN: 1043-321X
DOI: 10.1016/j.breastdis.2013.01.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus in Postmenopausal Hormone-Rec

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

✍ Baselga, José; Campone, Mario; Piccart, Martine; Burris, Howard A.; Rugo, Hope S 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 614 KB

The BOLERO-2 trial: the addition of ever

The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

✍ Beaver, Julia A; Park, Ben H 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 804 KB

Everolimus in Combination with Exemestan

Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB

Everolimus in hormone receptor–positive

Everolimus in hormone receptor–positive advanced breast cancer: Targeting receptor-based mechanisms of resistance

✍ Shtivelband, Mikhail I. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Role of Fulvestrant in Sequential Hormon

Role of Fulvestrant in Sequential Hormonal Therapy for Advanced, Hormone Receptor—Positive Breast Cancer in Postmenopausal Women

✍ Steven E. Come; Virginia F. Borges 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 549 KB

Everolimus overcomes hormonal resistance

Everolimus overcomes hormonal resistance in ER-positive breast cancer

✍ Jame Abraham 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 56 KB